Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament for treating dry eye

A dry eye and heavy technology, applied in the field of medicine, can solve the problems of palliative rather than root cause, easy dependence on eye drops, unbearable dry eyes, etc., and achieve the effect of repairing lacrimal gland, improving physiological function and immunity, and eliminating eye discomfort

Inactive Publication Date: 2011-07-06
谢立科
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to solve the existing dry eye treatment mainly using eye drops, eye drops can only temporarily relieve dry eye, treat the symptoms but not the root cause, and eye drops are also prone to dependence, once the drug is stopped, the eyes will become more severe problem of unbearable dryness, thus providing a remedy for dry eye

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0010] Embodiment 1: In this embodiment, a medicine for treating dry eye consists of 5 to 10 grams of Bupleurum, 10 to 20 grams of Radix Paeoniae Alba, 10 to 15 grams of Angelica, 8 to 15 grams of Radix Ophiopogon japonicus, and 5 to 10 grams of Peppermint by weight. , Codonopsis 10-15 grams, raw land 10-30 grams, Schisandra 5-15 grams and dextrin 80-100 grams. A preparation method of medicine for treating dry eye in this embodiment is as follows: soak the Bupleurum, Radix Paeoniae Alba, Angelica, Ophiopogon japonicus, Peppermint, Codonopsis Codonopsis, Rehmannia and Schisandra in water for 40 minutes, and the amount of water added is 16 times the total weight of peony root, angelica, radices japonicus, mint, codonopsis, raw land and schisandra, decoct for 1.5 to 2 hours, pour out the decoction, add 10 times of water and continue decocting for 1 hour, combine the two decoctions, Filtrate, concentrate under reduced pressure to a clear paste with a relative density of 1.35 (50-5...

specific Embodiment approach 2

[0011] Embodiment 2: In this embodiment, a medicine for treating dry eye consists of Bupleurum 6-9 grams, Radix Paeoniae Alba 11-19 grams, Angelica 11-14 grams, Ophiopogon japonicus 9-14 grams, and Peppermint 6-9 grams by weight. , Codonopsis 11-14 grams, raw land 11-29 grams, schisandra 6-14 grams and dextrin 85-95 grams. Others are the same as in the first embodiment.

specific Embodiment approach 3

[0012] Specific embodiment three: a kind of medicine for the treatment of dry eye in this embodiment consists of Bupleurum 7 grams, Radix Paeoniae Alba 15 grams, Angelica 13 grams, Radix Ophiopogon japonicus 12 grams, Peppermint 8 grams, Codonopsis 12 grams, Rehmannia 20 grams, Schisandra chinensis 13 grams and 90 grams of dextrin. Others are the same as in the first embodiment.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a medicament for treating a dry eye. The medicament for treating the dry eye is prepared from the following constituents by weight: 5-10 grams of bupleurum, 10-20 grams of white paeony root, 10-15 grams of Chinese angelica, 8-15 grams of dwarf lilyturf tuber, 5-10 grams of mint, 10-15 grams of campanumaea pilosula, 10-30 grams of rehmanniae praeparatum, 5-15 grams of Chinese magnoliavine fruit and 80-100 grams of dextrin. The medicine mainly aims at a patient with the dry eye and can be taken by the patient who is diagnosed with the dry eye in an outpatient department according to following usage and dosage: twice daily, a small bag each time by dissolving with warm water and 15 days for a course of treatment. No contraindication is needed to be noticed by orally taking this medicament. The medicament has effects of soothing the liver, nourishing yin and improving eye sight, human physiological function and immunity, has a certain action of imitating androgen, and can be used for dredging a lachrymal catheter, inhibiting inflammation, restoring tear gland, facilitating tear secretion by the tear gland, enabling dry and burning sensation of the eye to disappear and basically solving the problems of eye discomfort, eye acerbity, lachrymation, light sensitivity and visual deterioration.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating dry eye. Background technique [0002] The ocular surface part of the eye usually relies on the lacrimal gland to supply water. By blinking, the tears become a layer of "tear flakes" and disperse to the ocular surface to keep the eyes comfortable. The so-called "dry eye" refers to a multifactorial disease of the tear fluid and the surface of the eyeball, causing eye discomfort, visual disturbance, and tear film instability, damage to the eyeball surface, and accompanied by increased tear film permeability and ocular surface inflammation. . In the past, dry eye, cataract, glaucoma and other diseases were mainly common eye diseases of the elderly, but now it is found that in some cities, young people and white-collar workers who are often exposed to computers, TVs, and game consoles are suffering from dry eye. According to a survey conducted by relevant departments, 90% of pe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8968A61P27/02
Inventor 谢立科
Owner 谢立科
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products